Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies - FDA Press Releases

FDA issues two draft guidances that will provide medical product developers with greater clarity on the FDA’s recommendations for researching and developing the next generation of individualized therapies.

from Food and Drug Administration--Press Releases http://ift.tt/2Az5HMy
via IFTTT